Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
Cognitive rehabilitation correlates with the functional connectivity of the anterior cingulate cortex in patients with multiple sclerosis.
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
Estimated incidence of multiple sclerosis among United States Armed Forces personnel using the Defense Medical Surveillance System.
1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MS.
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.
Dilantin (phenytoin) Supplemental Approval Letter
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Major stressful life events in adulthood and risk of multiple sclerosis.
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
Riluzole enhances glutamate uptake in rat astrocyte cultures.
Psychiatric disorders in patients with multiple sclerosis.
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
Secukinumab shines in small MS trial
Scrub typhus with longitudinally extensive transverse myelitis.
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.
Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.
Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis.
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.

Pages